Top compounds associated with response to CT45A9


Feature Type Standardized
Nominal ANOVA
mRNA cediranib CTRPv2 pan-cancer AAC -0.089 0.09
mRNA CIL41 CTRPv2 pan-cancer AAC -0.084 0.09
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC -0.053 0.09
mRNA neratinib CTRPv2 pan-cancer AAC -0.058 0.09
mRNA piperlongumine CTRPv2 pan-cancer AAC -0.053 0.09
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC -0.059 0.09
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.1
mRNA ABT-888 CTRPv2 pan-cancer AAC -0.06 0.1
mRNA Vorinostat CTRPv2 pan-cancer AAC -0.053 0.1
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.1
Download CSV